Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vanicream Lite (now marketed as Vanicream Moisturizing Lotion) is a dermatologist-recommended, non-comedogenic emollient formulated for sensitive skin. Developed by Pharmaceutical Specialties, Inc. (PSI), the product is distinguished by its "free-of" profile, lacking common allergens and irritants such as fragrance, dyes, parabens, lanolin, and formaldehyde releasers. It functions by providing a protective barrier that helps retain skin moisture and soothe conditions like eczema, psoriasis, and general xerosis. In clinical research, Vanicream Lite is frequently utilized as a standardized placebo or vehicle control, notably in studies investigating topical treatments for dermatitis or vaginal conditions like atrophic vaginitis, due to its inert and highly tolerable formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vanicream Lite.